Rezolute Valuation Multiples

Rezolute Overview

About Rezolute

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute’s pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Founded

2010

HQ

Employees

71

Website

rezolutebio.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: —

Net Income: ($78M)

EV

$199M

Valuation Multiples

Multiples.vc

Start free trial

Rezolute Financials

Rezolute reported last 12-month revenue of —.

In the same LTM period, Rezolute generated — in gross profit and had net loss of ($78M).

Rezolute P&L

In the most recent fiscal year, Rezolute reported revenue of — and EBITDA of ($80M).

Rezolute expects next 12-month revenue of XXX and NTM EBITDA of XXX

Rezolute Stock Performance

Rezolute has current market cap of $330M, and enterprise value of $199M.

Rezolute's stock price is $3.45.

Rezolute Valuation Multiples

Rezolute trades at (2.5x) EV/EBITDA.

Rezolute Financial Valuation Multiples

As of April 18, 2026, Rezolute has market cap of $330M and EV of $199M.

Equity research analysts estimate Rezolute's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Rezolute has a P/E ratio of (4.2x).

Rezolute Margins & Growth Rates

Rezolute's revenue in the last fiscal year grew by —.

Rezolute's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.1M for the same period.

Rezolute Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Rezolute M&A Activity

Rezolute acquired XXX companies to date.

Last acquisition by Rezolute was on XXXXXXXX, XXXXX. Rezolute acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Rezolute Investment Activity

Rezolute invested in XXX companies to date.

Rezolute made its latest investment on XXXXXXXX, XXXXX. Rezolute invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).